MSEOs may demonstrate potential for treating insomnia by promoting neuronal proliferation in the brains of insomniac mice and upregulating the expression of GAD65, GABAARα1, 5HT-1A, and 5HT-2A proteins in various brain regions, potentially becoming an effective candidate for insomnia treatment. Here, HTR2A is linked to insomnia.